跳至主要内容
临床试验/JPRN-UMIN000028113
JPRN-UMIN000028113已完成未知

sefulness of TSPO-PET and related biomarkers in the patients with neuropathic pain - Usefulness of TSPO-PET in neuropathic pain

Osaka University Hospital0 个研究点目标入组 11 人开始时间: 2017年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 84years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • <Exclusion criteria for patients> 1. Pregnant women, nursing mothers and the women who may be pregnant. 2. The patients with the severe psycho-neurologic disease (major depression or schizophrenia). 3. Patients with a history of the severe injury with sliding symptoms due to a vertebral fracture and the backbone trauma within six months. 4. Patients with the discectomy, nerve cauterization, and vertebra plasty within six months. 5. Algetic patients due to articular rheumatism, ankylosing spondylitis, and spinal inflammation or tumor. 6. Patients who are unsolved accident compensation about the pain and financial mediation/suit. 7. Patients with a history of HIV. 8. Patients who are participating into other clinical trials. 9. Patients who are judged to be inadequate as subjects by the principal investigator. <Exclusion criteria for normal volunteers> 1. Pregnant women, nursing mothers and the women who may be pregnant. 2. Subjects with the severe psycho-neurologic disease (major depression or schizophrenia). 3. Subjects who suffer from hypertention, hyperlipidemia, vascular disease, and/or cardiac disease. 4. The subjects who have symptoms of pain. 5. Subjects who have claustrophobia. 6. Subjects who suffer from malignant tumors. 7. Subjects who have allergy. 8. Subjects who have smoking behavior and alcohol indulgence. 9. Subjects with a history of HIV. 10. Subjects who are participating into other clinical trials. 11. Subjects who are judged to be inadequate as subjects by the principal investigator.

研究者

相似试验